Lisdexamfetamine Dimesylate Capsules

SOL #: SPE2D2-26-R-0004Pre-Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Jan 20, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Lisdexamfetamine Dimesylate Capsules. This will be an unrestricted and fully competitive acquisition to establish a national supply source for Department of Defense, Indian Health Service, and Department of Veterans Affairs customers. The projected solicitation date is March of 2026.

Scope of Work

This opportunity seeks to procure Lisdexamfetamine Dimesylate Capsules in various strengths and bottle counts:

  • 10 MG, 20 MG, 30 MG, 40 MG, 50 MG, 60 MG, and 70 MG Capsules in 90 Count Bottles.
  • 10 MG, 20 MG, 30 MG, 40 MG, 50 MG, 60 MG, and 70 MG Capsules in 100 Count Bottles.

The resulting contract will establish a national supply source to provide these items through the DLA and VA prime vendor programs.

Contract & Timeline

  • Contract Type: Firm-Fixed Price, Requirements Type Contract (FAR 52.216-21)
  • Duration: One-year base period with four one-year option periods.
  • Set-Aside: Unrestricted and fully competitive.
  • Procurement Method: Commercial item acquisition using FAR Part 12.
  • Projected Solicitation Date: March 2026 (DLA reserves the right to issue before or after this date).
  • Published: January 20, 2026

Evaluation

All sources may submit a proposal, which shall be considered by the agency. Annual usage estimates will be provided in the Schedule of Supplies section of the forthcoming solicitation.

Additional Notes

The solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties are advised to set up automated notifications for updates. For questions, contact Courtney Hunter at Courtney.Hunter@dla.mil or (445) 737-3585.

People

Points of Contact

Courtney HunterPRIMARY
Jason WraySECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Pre-Solicitation
Posted: Jan 20, 2026
Lisdexamfetamine Dimesylate Capsules | GovScope